MENU
+Compare
MIRM
Stock ticker: NASDAQ
AS OF
Jun 26, 10:54 AM (EDT)
Price
$49.55
Change
-$0.58 (-1.16%)
Capitalization
2.48B

MIRM Mirum Pharmaceuticals Forecast, Technical & Fundamental Analysis

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more

MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MIRM with price predictions
Jun 25, 2025

MIRM sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MIRM moved above the 200-day moving average on June 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on MIRM as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MIRM just turned positive on June 06, 2025. Looking at past instances where MIRM's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 254 cases where MIRM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MIRM moved out of overbought territory on June 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MIRM broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.650) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). MIRM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (6.345) is also within normal values, averaging (255.605).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MIRM is expected to report earnings to rise 10.37% to -33 cents per share on July 31

Mirum Pharmaceuticals MIRM Stock Earnings Reports
Q2'25
Est.
$-0.33
Q1'25
Beat
by $0.01
Q4'24
Missed
by $1.55
Q3'24
Beat
by $0.15
Q2'24
Missed
by $0.05
The last earnings report on May 07 showed earnings per share of -30 cents, beating the estimate of -31 cents. With 2.90K shares outstanding, the current market capitalization sits at 2.48B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGRCX26.76N/A
N/A
Fidelity Advisor Mega Cap Stock C
HMVCX10.50N/A
N/A
Hartford MidCap Value C
HIASX17.47N/A
N/A
Hartford Small Company HLS IA
NPSGX15.32N/A
N/A
Nicholas Partners Small Cap Gr Instl
CFNCX86.08-0.13
-0.15%
American Funds Fundamental Invs 529C

MIRM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with CRNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
-1.92%
CRNX - MIRM
46%
Loosely correlated
-1.71%
ZNTL - MIRM
43%
Loosely correlated
-2.96%
APGE - MIRM
41%
Loosely correlated
-1.29%
RARE - MIRM
41%
Loosely correlated
+0.73%
IDYA - MIRM
40%
Loosely correlated
+1.06%
More